9 June 2025 - Pfizer and other drug companies have met with the Trump administration to discuss lowering US drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.
President Donald Trump issued an executive order last month directing drug makers to lower the prices of their medicines to align with what other countries pay.